Recombinant SARS-CoV-2 Nucleocapsid antibody

Catalog No. ABIN6973311

This anti-SARS-CoV-2 Nucleocapsid antibody is a Human Monoclonal antibody detecting SARS-CoV-2 Nucleocapsid in ELISA. Suitable for SARS Coronavirus-2 (SARS-CoV-2).

Quick Overview for Recombinant SARS-CoV-2 Nucleocapsid antibody (ABIN6973311)

Target: SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

Antibody Type: Recombinant Antibody

Reactivity: SARS Coronavirus-2 (SARS-CoV-2)

Host: Human

Clonality: Monoclonal

Conjugate: This SARS-CoV-2 Nucleocapsid antibody is un-conjugated

Application: ELISA

Clone: CR3018

Product Details anti-SARS-CoV-2 Nucleocapsid Antibody

Specificity: Nucleoprotein of SARS-CoV-2 (aa 11-19) which corresponds to the sequence RSAPRITFG of the N protein of SARS-CoV

Immunogen: Recombinant antibody from a phage display library,Generated by sequencing peripheral blood lymphocytes of a patient exposed to the SARS-CoV

Isotype: IgG, kappa

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Buffer: Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free

Preservative: Without preservative

Storage: 4 °C

Storage Comment: Stable at +2-8°C for 12 months. For longer storage freeze aliquots.

Target Details for SARS-CoV-2 Nucleocapsid

Target: SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)

Alternative Name: SARS-CoV-2 Nucleoprotein

Target Type: Viral Protein

Background: Nucleoprotein / SARS-CoV nucleoprotein / Nucleocapsid protein